Found: 5
Select item for more details and to access through your institution.
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
- Published in:
- Kidney International, 2013, v. 84, n. 5, p. 1025, doi. 10.1038/ki.2013.211
- By:
- Publication type:
- Article
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.
- Published in:
- Nature Medicine, 2008, v. 14, n. 9, p. 931, doi. 10.1038/nm.1857
- By:
- Publication type:
- Article
Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 85, p. 1, doi. 10.1126/scitranslmed.3002231
- By:
- Publication type:
- Article
Podocyte-Specific GLUT4-Deficient Mice Have Fewer and Larger Podocytes and Are Protected From Diabetic Nephropathy.
- Published in:
- Diabetes, 2014, v. 63, n. 2, p. 701, doi. 10.2337/db13-0752
- By:
- Publication type:
- Article
Cyclodextrin Protects Podocytes in Diabetic Kidney Disease.
- Published in:
- Diabetes, 2013, v. 62, n. 11, p. 3817, doi. 10.2337/db13-0399
- By:
- Publication type:
- Article